Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Daphnetin
The First People's Hospital of Lianyungang
Lower Extremity Lymphedema
1 trial -
Dental foam "Biorepair PERIBIOMA"
The First People's Hospital of Lianyungang
Oral Health
1 trial -
Desmopressin
The First People's Hospital of Lianyungang
Patients Undergoing Endoscopic Sinus Surgery
1 trial -
Dex-Esk
The First People's Hospital of Lianyungang
Older Patients
1 trial -
Dexamethasone
The First People's Hospital of Lianyungang
Pancreatic Cancer
1 trial -
Dexamethasone
The First People's Hospital of Lianyungang
Carcinoma, Non-Small-Cell Lung
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Older Patients
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Renal Function
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Postoperative Delirium After Living Donor Renal Transplantation
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Overall Survival
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Obstructive Sleep Apnea
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Elderly
3 trials -
Dexmedetomidine
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
Dexmedetomidine-esketamine combination
The First People's Hospital of Lianyungang
Obstructive Sleep Apnea
1 trial -
Diane-35 pretreatment
The First People's Hospital of Lianyungang
Polycystic Ovary Syndrome
1 trial -
Edaravone dexborneol
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
Esketamine
The First People's Hospital of Lianyungang
Scoliosis Correction
1 trial -
Esketamine
The First People's Hospital of Lianyungang
Postpartum Depression
1 trial -
Esketamine 0.2 mg/kg
The First People's Hospital of Lianyungang
Cesarean Delivery
1 trial -
Esketamine 1
The First People's Hospital of Lianyungang
Elderly
1 trial -
Esketamine combined with dexmedetomidine
The First People's Hospital of Lianyungang
Dexmedetomidine
2 trials -
Exenatide
The First People's Hospital of Lianyungang
Type 2 Diabetes
1 trial -
Flumatinib
The First People's Hospital of Lianyungang
Flumatinib
1 trial -
Folic Acid
The First People's Hospital of Lianyungang
Hypertension
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources